






























$0.80 Earnings Per Share Expected for Steris Plc (STE) This Quarter - Chaffey Breeze













































 
















 



  
 
 
























Daily Ratings & News for Steris Plc

        
	Complete the form below to receive the latest headlines and analysts' recommendationsfor Steris Plc with our free daily email newsletter:










Follow @chaffeybreeze












Recent Posts

Zacks Investment Research Downgrades Hillenbrand Inc (NYSE:HI) to Hold
Netflix, Inc. (NFLX) Price Target Increased to $225.00 by Analysts at BTIG Research
Raymond James Financial, Inc. Cuts United Community Banks, Inc. (NASDAQ:UCBI) Price Target to $31.00
Chubb Ltd (NYSE:CB) Price Target Raised to $160.00 at Raymond James Financial, Inc.
Berkshire Hathaway (NYSE:BRK-B) Earns Daily Coverage Optimism Score of 0.07
Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Bristow Group (NYSE:BRS) Stock Price
Lifetime Brands (NASDAQ:LCUT) Earns News Impact Score of 0.19
Akamai Technologies, Inc. (NASDAQ:AKAM) Stock Rating Reaffirmed by Piper Jaffray Companies
Trecora Resources (NYSE:TREC) Getting Somewhat Positive Press Coverage, Report Shows
Guaranty Bancshares (NASDAQ:GNTY) Earns Daily News Impact Score of 0.15
Zacks: Brokerages Expect Baxter International Inc. (BAX) Will Announce Earnings of $0.57 Per Share
Comparing Limoneira (LMNR) & Landec Corporation (LNDC)
Tutor Perini Corporation (TPC) versus Orion Group Holdings (ORN) Critical Comparison
Allegion PLC (ALLE) versus FLIR Systems (FLIR) Financial Analysis
ConocoPhillips (NYSE:COP) Releases Quarterly  Earnings Results, Beats Expectations By $0.16 EPS
Potash Corporation of Saskatchewan Inc. (NYSE:POT) Issues FY17 Earnings Guidance
Washington Prime Group Inc. (WPG) Updates FY17 Earnings Guidance
Royal Mail PLC (RMG) Given New GBX 385 Price Target at Liberum Capital
Applied Materials, Inc. (AMAT) Upgraded to Buy at Vetr Inc.
Burford Capital Limited (BUR) Coverage Initiated by Analysts at Berenberg Bank







$0.80 Earnings Per Share Expected for Steris Plc (STE) This Quarter


					Posted by Oliver Carreras on Jul 19th, 2017 // No Comments




Analysts expect Steris Plc (NYSE:STE) to post earnings per share of $0.80 for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for Steris Plc’s earnings, with the highest EPS estimate coming in at $0.82 and the lowest estimate coming in at $0.78. Steris Plc posted earnings of $0.79 per share during the same quarter last year, which would indicate a positive year over year growth rate of 1.3%. The firm is scheduled to announce its next earnings report  on Tuesday, August 8th.
According to Zacks, analysts expect that Steris Plc will report full-year earnings of $4.06 per share for the current financial year, with EPS estimates ranging from $4.05 to $4.08. For the next financial year, analysts expect that the business will report earnings of $4.53 per share, with EPS estimates ranging from $4.51 to $4.57. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of research analysts that follow Steris Plc.


 Get Steris Plc alerts:



Steris Plc (NYSE:STE) last announced its quarterly earnings results on Tuesday, May 9th. The medical equipment provider reported $1.11 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.07 by $0.04. The firm had revenue of $681.20 million during the quarter, compared to the consensus estimate of $673.47 million. Steris Plc had a return on equity of 11.12% and a net margin of 4.20%. The firm’s quarterly revenue was down 1.3% compared to the same quarter last year. During the same period in the prior year, the company posted $0.90 earnings per share. 





STE has been the subject of a number of analyst reports. Zacks Investment Research upgraded Steris Plc from a “sell” rating to a “hold” rating in a research report on Wednesday, March 22nd. Wellington Shields lowered Steris Plc from a “gradually accumulate” rating to a “hold” rating in a research report on Monday, June 5th. Finally, KeyCorp upgraded Steris Plc from a “sector weight” rating to an “overweight” rating and set a $89.00 price target for the company in a research report on Wednesday, May 3rd. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. Steris Plc currently has an average rating of “Buy” and a consensus price target of $84.00.
Steris Plc (STE) opened at 81.91 on Wednesday. Steris Plc has a one year low of $63.80 and a one year high of $83.54. The company has a 50-day moving average price of $81.05 and a 200-day moving average price of $73.40. The firm has a market capitalization of $6.96 billion, a P/E ratio of 63.99 and a beta of 1.33. 
The firm also recently declared a quarterly dividend, which was paid on Thursday, June 29th. Shareholders of record on Wednesday, June 7th were given a dividend of $0.28 per share. The ex-dividend date  was Monday, June 5th. This represents a $1.12 dividend on an annualized basis and a yield of 1.37%. Steris Plc’s dividend payout ratio (DPR) is presently 87.50%. 
In other news, CFO Michael J. Tokich sold 13,600 shares of the business’s stock in a transaction on Tuesday, May 9th. The stock was sold at an average price of $76.00, for a total value of $1,033,600.00. Following the sale, the chief financial officer now owns 58,106 shares of the company’s stock, valued at approximately $4,416,056. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Michael B. Wood sold 4,000 shares of the business’s stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $81.50, for a total value of $326,000.00. Following the completion of the sale, the director now directly owns 26,131 shares in the company, valued at approximately $2,129,676.50. The disclosure for this sale can be found here. Insiders sold a total of 60,880 shares of company stock worth $4,738,494 in the last three months. Company insiders own  2.55% of the company’s stock. 
Hedge funds have recently bought and sold shares of the company. Louisiana State Employees Retirement System increased its stake in  Steris Plc by 1.4% in the first quarter. Louisiana State Employees Retirement System now owns 21,400 shares of the medical equipment provider’s stock worth $1,486,000 after buying an additional 300 shares in the last quarter.  Norges Bank purchased a new stake in  Steris Plc during the fourth quarter worth approximately $45,178,000.  Russell Investments Group Ltd. increased its stake in  Steris Plc by 57.5% in the first quarter. Russell Investments Group Ltd. now owns 132,035 shares of the medical equipment provider’s stock worth $9,171,000 after buying an additional 48,188 shares in the last quarter.  Washington Capital Management Inc. increased its stake in  Steris Plc by 35.6% in the first quarter. Washington Capital Management Inc. now owns 8,000 shares of the medical equipment provider’s stock worth $556,000 after buying an additional 2,100 shares in the last quarter.  Finally, Bragg Financial Advisors Inc purchased a new stake in  Steris Plc during the first quarter worth approximately $1,159,000. 90.43% of the stock is currently owned by institutional investors. 
TRADEMARK VIOLATION NOTICE: “$0.80 Earnings Per Share Expected for Steris Plc (STE) This Quarter” was originally  posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this piece on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The original version of this piece can be accessed at https://www.chaffeybreeze.com/2017/07/19/0-80-earnings-per-share-expected-for-steris-plc-ste-this-quarter.html. 
About Steris Plc
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Get a free copy of the Zacks research report on Steris Plc (STE)
For more information about research offerings from Zacks Investment Research, visit Zacks.com






Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with MarketBeat.com's FREE daily email newsletter.








 






















Latest News





Leave a Reply

Click here to cancel reply.




Name  (Required) 



Mail (will not be published)  (Required) 



Website












 

 











































    Daniel Carestio | STERIS Corporation | ZoomInfo.com﻿







Daniel Carestio Sold 881 shares of STERIS Corp (NYSE:STE) in an Insider Trade – Octafinance























































 








Thursday, 27 July 2017

























 

Menu



Featured News


						2 years ago - Alphabet Inc (NASDAQ:GOOGL) Tests Its Ad Technology On Billboards To Cushion Itself Against Ad Blocks


						2 years ago - China Margin Debt Hits 8-Week High, Japan Pumps’n’Dumps As Kyle Bass Fears Looming EM Banking Crisis


						2 years ago - Marc Faber Shares His Insight in One Hour Exclusive Interview. He Covers All From Commodities and China to Inflation, The Euro and Gold


						2 years ago - Carl Icahn Criticizes the Fed. Feels Bad For Investors Buying Junk Bonds


						2 years ago - John Burbank: European QE Can’t Save The Markets Same As the U.S. Quantitative Easing. Everything Will Be Liquidated










Daniel Carestio Sold 881 shares of STERIS Corp (NYSE:STE) in an Insider Trade


10/22/2015  by OctaStaff 
			in Insider News 












Share with your friendsYour NameYour EmailRecipient EmailEnter a MessageI read this article and found it very interesting, thought it might be interesting for you. The article is called Daniel Carestio Sold 881 shares of STERIS Corp (NYSE:STE) in an Insider Trade and is was published by Octafinance.com at http://www.octafinance.com/daniel-carestio-sold-881-shares-of-steris-corp-nyseste-in-an-insider-trade/235802/.CaptchaSubmit
Daniel Carestio Insider Sell Transaction
 Daniel Carestio, the well informed person, who is also the Sr. V. P. – Isomedix & Life Sci of STERIS Corp (NYSE:STE)  82.01 -0.48 -0.58% sold approx. 881 shares of the corporation that are worth approx. $60,130 U.S Dollars based on a market stock price of 68.3 U.S Dollars a share. Right now, he has in hand 23,070 shares or 0.04% of the Company’s total market cap. 
Steris Corp Stock Rating, Sentiment and Fundamentals
 According to eight financial analysts that are covering this firm’s future, there is an expectation of earnings-per-share of $3.25 for the 2015 year, which gives Steris Corp a PE ratio of 20.84. The expert analysts suspect Steris Corp’s earnings growth rate year on year is going to be 10.00%.






Rating & SentimentPsychSignal Social:SELLAnalysts Rating:BUYHedge Funds Sentiment:BUY




Stock FundamentalsEarnings + FCF Trend:BUYSector/Industry Macro:BULLISHValuation Models:-


 


Technical AnalysisST Trend:UPMT Trend:NEUTRALLT Trend:UP




OctaFinance Rating*:NEUTRAL


* Read How Our Stock Ratings System Works








 In the last 125 days alone the Steris Corp’s share price has risen 2.43% and continues to smoothly trend up. OctaFinance’s time momentum model, coupled with Daniel’s new stock trade, gives us no choice but to rate the stock “NEUTRAL”.
Price Chart of Steris Corp NYSE:STE Stock
 
Source: RightEdgeSystems, Yahoo Split & Dividend Adjusted Data and OctaFinance Interpretations
Hedge Funds Ownership
 As of Q2 2015, 286 hedge funds and institutional investors own shares of Steris Corp. The tracked institutional players have historically had a very high interest in Steris Corp’s stock, and that was also the case in Q2 2015. The institutional ownership was 103.69% of the stock’s outstanding shares. They decreased by 750,653 the total shares they hold. As of that quarter these funds owned 62.05 million shares. There were 43 funds that created new positions and 107 funds that added to their positions. A total of 43 funds closed their positions in Steris Corp and 98 reduced their holdings.
 As published by SEC’s 13F filings, this company is in Top 10 stock positions of three institutional funds. These funds are: Cramer Rosenthal Mcglynn Llc, Ridgeworth Capital Management Llc, Hillcrest Asset Management Llc.

 Cramer Rosenthal Mcglynn Llc is the most bullish institutional investor on Steris Corp, with ownership of 2.30 million shares as of Q2 2015 for 1.83% of the fund’s portfolio. Ridgeworth Capital Management Llc is another bullish investment manager having 3.15 million shares of the company or 1.51% of their stocks portfolio. The stock is also 0.73% of the fund’s AUM. The Texas-based fund Hillcrest Asset Management Llc have 2.56% of their stock portfolio invested in the stock for 131,309 shares. Moreover, Leighton Welch’s Welch Capital Partners Llc Ny revealed it had acquired a stake worth 3.76% of the fund’s stock portfolio in the company. West Coast Financial Llc was also a notable follower of the Ohio-based company, owning 75,891 shares. Steris Corp is 2.15% of the fund’s stock portfolio.
STERIS Corp NYSE:STE Company Profile

STERIS Corporation (STERIS) is a provider of infection prevention and other procedural products and services, focused primarily on healthcare, pharmaceutical and research. The Company operates in three segments: Healthcare, Life Sciences, and STERIS Isomedix Services. The Healthcare segment manufactures and sells capital equipment, accessory, consumables, information support and service solutions to healthcare providers, including acute care hospitals and surgery and gastrointestinal (GI) centers. The Life Sciences segment manufactures and sells a range of capital equipment, formulated cleaning chemistries, and service solutions to pharmaceutical companies and private and public research facilities. The Isomedix segment sells an array of contract processing services, as well as laboratory testing services. It offers microbial reduction services based on Customer specifications to companies that supply products to the healthcare, industrial, and consumer product industries.
Company Website: STERIS Corp
 Steris Corp was filled in Ohio on 1985-08-09. At the moment its market worth is: $4.05 billion and it has 58.87 million shares outstanding. This company has 7600 employees. Today the company has 108.12% shareholders and the institutional ownership is 108.12%. The stock closed at $68.800003 yesterday and it had average 2 days volume of 225334 shares. It is up from the 30 days average shares volume of 208333. Steris Corp has a 52 weeks low of $59.11 and a 52w high of $71.33. The current price is above the 200 days SMA. Steris Corp last issued its quarterly earnings information on 08/04/2015. The company reported 0.62 EPS for the quarter, above the consensus estimate of 0.6 by 0.02. The company had a revenue of 439.90 million for 6/30/2015 and 501.65 million for 3/31/2015. Therefore, the revenue was -61,745,000 down.
* This transaction involved the open market sale on October 20 – 2015 of a total of 881 shares – held by the Reporting Person – pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person – effective June 11 – 2015.
* This represents the average sales price of the 881 shares sold in the open market. The actual six sales prices ranged from $68.00 per share to $68.62 per share. Issuer – upon request by the SEC staff – will provide full information regarding the number of shares sold at each of these six sales prices.
* 16 – 800 of these Common Shares are restricted. The restrictions on these Common Shares lapse as follows: 4 – 500 on May 31 – 2016; 3 – 300 on May 31 – 2017; 4 – 000 on May 30 – 2018; and 5 – 000 on May 28 – 2019.

STERIS Corp - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.



 



 
Tagged: Daniel CarestioSTERIS Corp - (NYSE:STE)



athenahealth, Inc (NASDAQ:ATHN)’s EVP Client Organization Stephen Kahane Unloaded 2,000 Shares Advaxis, Inc. (NASDAQ:ADXS)’s Chief Medical Officer David Mauro Sold 24586 shares of the Company 



 





STERIS Corp - Get News & Ratings Daily
    Enter your email address below to get the latest news and analysts' ratings for STERIS Corp with our FREE daily email newsletter:



 



Hedge Fund NewsTop 10 CITADEL ADVISORS 13F Holdings in Q3 2015DF DENT & CO INC Just Released Its Q3 2015 Stock PositionsMAVERICK CAPITAL Top 10 Holdings in Q3 2015Analyzing Ken Griffins CITADEL ADVISORS Stock Holdings in Q3 2015LONE PINE CAPITAL Top 10 13F Positions in Q3 2015Guru NewsFelix Zulauf Sees a Stock Market Correction Coming. This Rally S&P 500 (INDEXSP:.INX) Will Be Short-LivedMarc Faber Shares His Insight in One Hour Exclusive Interview. He Covers All From Commodities and China to Inflation, The Euro and GoldJim Grant: The Next Thing Might Be Helicopter Money. What to Buy and Where He Sees Investment OpportunitiesKyle Bass Bearish on Emerging Markets for at least 2 More Years. Looking to Short CurrenciesDavid Tepper Gets Defensive. Is it Time to Get Out of The Stock Market?


Macro NewsChina Margin Debt Hits 8-Week High, Japan Pumps’n’Dumps As Kyle Bass Fears Looming EM Banking CrisisAre US – Russian Relations A Zero-Sum Game?US and Russia have launched direct talks on the conflict in SyriaYuan Drops as PBOC Cuts Reference Rate by Most Since DevaluationCould the market crash like 1987?—put volume spike argues low is nearCTAs NewsRed Rock Just Published Report About The Trend Following Landscape & How CTAs’ Performance Must Be AnalyzedHow to Implement Dual Momentum for non-US InvestorsDo Commodity Trading Advisors (CTAs) Really Provide Crisis Alpha, Equity Hedge and Are Long Volatility?


























Legato Capital Management LLC Purchases 21,948 Shares of STERIS PLC (NYSE:STE) | Daily Political











































































Home
About/Contact
Columnists
Privacy Policy
























Headlines
Politics
Nation
World
Issues
Economy
Finance




















STERIS PLC - Get News & Ratings Daily

		Enter your email address below to get the latest news and analysts' ratings for STERIS PLC with our FREE daily email newsletter:



 






Follow DailyPolitical

 
 










Latest News



Viking Fund Management LLC Acquires 41,000 Shares of Williams Companies, Inc. (The) (NYSE:WMB)					

j2 Global, Inc. (NASDAQ:JCOM) Shares Bought by Legato Capital Management LLC					

Legato Capital Management LLC Purchases Shares of 109,601 Investors Bancorp, Inc. (NASDAQ:ISBC)					

Legato Capital Management LLC Buys Shares of 73,900 Continental Building Products, Inc. (NYSE:CBPX)					

Legato Capital Management LLC Takes Position in Meta Financial Group, Inc. (NASDAQ:CASH)					

Legato Capital Management LLC Takes Position in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI)					

Legato Capital Management LLC Purchases 21,948 Shares of STERIS PLC (NYSE:STE)					

Van Berkom & Associates Inc. Acquires 63,235 Shares of Haemonetics Corporation (NYSE:HAE)					

Van Berkom & Associates Inc. Decreases Stake in Fox Factory Holding Corp. (NASDAQ:FOXF)					

Legato Capital Management LLC Sells 2,500 Shares of Credicorp Ltd. (NYSE:BAP)					

Van Berkom & Associates Inc. Cuts Position in Neustar, Inc. (NYSE:NSR)					

Van Berkom & Associates Inc. Has $54.38 Million Stake in Silicon Laboratories, Inc. (NASDAQ:SLAB)					

Globus Medical, Inc. (NYSE:GMED) Stake Raised by Van Berkom & Associates Inc.					

Moody’s Corporation (MCO) Issues  Earnings Results, Beats Estimates By $0.18 EPS					

Del Frisco’s Restaurant Group, Inc. (DFRG) Announces Quarterly  Earnings Results, Misses Estimates By $0.02 EPS					

Financial Analysis: On Deck Capital (ONDK) & Medallion Financial Corp. (NASDAQ:MFIN)					

Hydrogenics Corporation (HYGS) versus Pioneer Power Solutions (PPSI) Head-To-Head Review					

Comparing Tech Data Corporation (TECD) & Best Buy Co. (BBY)					

Critical Survey: AZZ (AZZ) vs. Emerson Electric (EMR)					

Somewhat Positive Media Coverage Somewhat Unlikely to Impact Kinder Morgan Management (NYSE:KMR) Share Price					





 





						Legato Capital Management LLC Purchases 21,948 Shares of STERIS PLC (NYSE:STE)					

						 July 21st, 2017  - 0 comments - Filed Under -
 by Jeff Wilder 


							Filed Under: Finance - SEC Filing Articles 







Tweet










Legato Capital Management LLC boosted its stake in  STERIS PLC (NYSE:STE) by 25.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor  owned 107,526 shares of the medical equipment provider’s stock after buying an additional 21,948 shares during the period. STERIS PLC makes up  about  3.7% of Legato Capital Management LLC’s holdings, making the stock its 4th largest position. Legato Capital Management LLC owned about 0.13% of STERIS PLC worth $8,763,000 at the end of the most recent quarter. 
Other large investors have also recently bought and sold shares of the company. BTIM Corp. raised its stake in  STERIS PLC by 2.7% in the first quarter. BTIM Corp. now owns 93,799 shares of the medical equipment provider’s stock valued at $6,515,000 after buying an additional 2,436 shares during the last quarter.  NBW Capital LLC raised its stake in  STERIS PLC by 24.0% in the first quarter. NBW Capital LLC now owns 47,312 shares of the medical equipment provider’s stock valued at $3,286,000 after buying an additional 9,170 shares during the last quarter.  Nationwide Fund Advisors raised its stake in  STERIS PLC by 16.2% in the first quarter. Nationwide Fund Advisors now owns 540,723 shares of the medical equipment provider’s stock valued at $37,559,000 after buying an additional 75,379 shares during the last quarter.  Diversified Trust Co raised its stake in  STERIS PLC by 7.8% in the first quarter. Diversified Trust Co now owns 3,816 shares of the medical equipment provider’s stock valued at $265,000 after buying an additional 275 shares during the last quarter.  Finally, Louisiana State Employees Retirement System raised its stake in  STERIS PLC by 1.4% in the first quarter. Louisiana State Employees Retirement System now owns 21,400 shares of the medical equipment provider’s stock valued at $1,486,000 after buying an additional 300 shares during the last quarter. 90.43% of the stock is currently owned by institutional investors and hedge funds. 
STERIS PLC (STE) traded down 0.13% on Friday, hitting $82.08. 76,438 shares of the company traded hands. The stock has a market cap of $6.98 billion, a PE ratio of 64.12 and a beta of 1.33. The stock’s 50-day moving average is $81.32 and its 200 day moving average is $73.52. STERIS PLC has a 12 month low of $63.80 and a 12 month high of $83.54. 




STERIS PLC (NYSE:STE) last released its quarterly earnings data on Tuesday, May 9th. The medical equipment provider reported $1.11 EPS for the quarter, topping analysts’ consensus estimates of $1.07 by $0.04. The firm had revenue of $681.20 million for the quarter, compared to the consensus estimate of $673.47 million. STERIS PLC had a net margin of 4.20% and a return on equity of 11.12%. The firm’s revenue was down 1.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.90 earnings per share.  Equities research analysts expect that  STERIS PLC will post $4.04 earnings per share for the current fiscal year. 
The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 29th. Investors of record on Wednesday, June 7th were issued a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a yield of 1.36%. The ex-dividend date of this dividend  was Monday, June 5th. STERIS PLC’s dividend payout ratio  is currently 87.50%. 
COPYRIGHT VIOLATION WARNING: This news story was first  published by Daily Political and is the property of of Daily Political. If you are viewing this news story on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this news story can be viewed at https://www.dailypolitical.com/2017/07/21/legato-capital-management-llc-purchases-21948-shares-of-steris-plc-nyseste.html. 
STE has been the subject of several research analyst reports. Zacks Investment Research upgraded shares of STERIS PLC from a “hold” rating to a “buy” rating and set a $92.00 price target for the company in a research report on Tuesday, July 11th. Wellington Shields downgraded shares of STERIS PLC from a “gradually accumulate” rating to a “hold” rating in a research report on Monday, June 5th. Finally, KeyCorp upgraded shares of STERIS PLC from a “sector weight” rating to an “overweight” rating and set a $89.00 price target for the company in a research report on Wednesday, May 3rd. Two investment analysts have rated the stock with a hold rating and three have issued  a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $84.00.
In related news, insider Kathleen Bardwell sold 3,795 shares of the business’s stock in a transaction dated Friday, June 16th. The shares were sold at an average price of $82.00, for a total transaction of $311,190.00. Following the sale, the insider now owns 20,605 shares of the company’s stock, valued at $1,689,610. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Michael J. Tokich sold 13,600 shares of the business’s stock in a transaction dated Tuesday, May 9th. The stock was sold at an average price of $76.00, for a total transaction of $1,033,600.00. Following the sale, the chief financial officer now directly owns 58,106 shares in the company, valued at approximately $4,416,056. The disclosure for this sale can be found here. In the last three months, insiders have sold 60,880 shares of company stock worth $4,738,494. 2.55% of the stock is owned by insiders. 
STERIS PLC Company Profile
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS PLC (NYSE:STE).






Receive News & Ratings for STERIS PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS PLC and related companies with MarketBeat.com's FREE daily email newsletter.



 
















 Comment on this Post

Click here to cancel reply.



Name (required)

Mail (will not be published) (required)

Website






Wordpress Hashcash needs javascript to work, but your browser has javascript disabled. Your comment will be placed in moderation!




Latest News




Jeff Sessions Spoke of Resigning After Tensions Increase with Trump





President Trump’s Tweets Complicate Already Complicated Week





World Leaders Very Critical of Paris Agreement Decision by Trump





Aide to President Trump Resigns With More Expected





Scud-Class Missile Launched by North Korea














			© DailyPolitical, LLC 2009-2017. All rights reserved. 


Privacy Policy |
			About | Columnists 
			| Contact 































































Legato Capital Management LLC Purchases 21,948 Shares of STERIS PLC (NYSE:STE) | Daily Political











































































Home
About/Contact
Columnists
Privacy Policy
























Headlines
Politics
Nation
World
Issues
Economy
Finance




















STERIS PLC - Get News & Ratings Daily

		Enter your email address below to get the latest news and analysts' ratings for STERIS PLC with our FREE daily email newsletter:



 






Follow DailyPolitical

 
 










Latest News



Viking Fund Management LLC Acquires 41,000 Shares of Williams Companies, Inc. (The) (NYSE:WMB)					

j2 Global, Inc. (NASDAQ:JCOM) Shares Bought by Legato Capital Management LLC					

Legato Capital Management LLC Purchases Shares of 109,601 Investors Bancorp, Inc. (NASDAQ:ISBC)					

Legato Capital Management LLC Buys Shares of 73,900 Continental Building Products, Inc. (NYSE:CBPX)					

Legato Capital Management LLC Takes Position in Meta Financial Group, Inc. (NASDAQ:CASH)					

Legato Capital Management LLC Takes Position in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI)					

Legato Capital Management LLC Purchases 21,948 Shares of STERIS PLC (NYSE:STE)					

Van Berkom & Associates Inc. Acquires 63,235 Shares of Haemonetics Corporation (NYSE:HAE)					

Van Berkom & Associates Inc. Decreases Stake in Fox Factory Holding Corp. (NASDAQ:FOXF)					

Legato Capital Management LLC Sells 2,500 Shares of Credicorp Ltd. (NYSE:BAP)					

Van Berkom & Associates Inc. Cuts Position in Neustar, Inc. (NYSE:NSR)					

Van Berkom & Associates Inc. Has $54.38 Million Stake in Silicon Laboratories, Inc. (NASDAQ:SLAB)					

Globus Medical, Inc. (NYSE:GMED) Stake Raised by Van Berkom & Associates Inc.					

Moody’s Corporation (MCO) Issues  Earnings Results, Beats Estimates By $0.18 EPS					

Del Frisco’s Restaurant Group, Inc. (DFRG) Announces Quarterly  Earnings Results, Misses Estimates By $0.02 EPS					

Financial Analysis: On Deck Capital (ONDK) & Medallion Financial Corp. (NASDAQ:MFIN)					

Hydrogenics Corporation (HYGS) versus Pioneer Power Solutions (PPSI) Head-To-Head Review					

Comparing Tech Data Corporation (TECD) & Best Buy Co. (BBY)					

Critical Survey: AZZ (AZZ) vs. Emerson Electric (EMR)					

Somewhat Positive Media Coverage Somewhat Unlikely to Impact Kinder Morgan Management (NYSE:KMR) Share Price					





 





						Legato Capital Management LLC Purchases 21,948 Shares of STERIS PLC (NYSE:STE)					

						 July 21st, 2017  - 0 comments - Filed Under -
 by Jeff Wilder 


							Filed Under: Finance - SEC Filing Articles 







Tweet










Legato Capital Management LLC boosted its stake in  STERIS PLC (NYSE:STE) by 25.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor  owned 107,526 shares of the medical equipment provider’s stock after buying an additional 21,948 shares during the period. STERIS PLC makes up  about  3.7% of Legato Capital Management LLC’s holdings, making the stock its 4th largest position. Legato Capital Management LLC owned about 0.13% of STERIS PLC worth $8,763,000 at the end of the most recent quarter. 
Other large investors have also recently bought and sold shares of the company. BTIM Corp. raised its stake in  STERIS PLC by 2.7% in the first quarter. BTIM Corp. now owns 93,799 shares of the medical equipment provider’s stock valued at $6,515,000 after buying an additional 2,436 shares during the last quarter.  NBW Capital LLC raised its stake in  STERIS PLC by 24.0% in the first quarter. NBW Capital LLC now owns 47,312 shares of the medical equipment provider’s stock valued at $3,286,000 after buying an additional 9,170 shares during the last quarter.  Nationwide Fund Advisors raised its stake in  STERIS PLC by 16.2% in the first quarter. Nationwide Fund Advisors now owns 540,723 shares of the medical equipment provider’s stock valued at $37,559,000 after buying an additional 75,379 shares during the last quarter.  Diversified Trust Co raised its stake in  STERIS PLC by 7.8% in the first quarter. Diversified Trust Co now owns 3,816 shares of the medical equipment provider’s stock valued at $265,000 after buying an additional 275 shares during the last quarter.  Finally, Louisiana State Employees Retirement System raised its stake in  STERIS PLC by 1.4% in the first quarter. Louisiana State Employees Retirement System now owns 21,400 shares of the medical equipment provider’s stock valued at $1,486,000 after buying an additional 300 shares during the last quarter. 90.43% of the stock is currently owned by institutional investors and hedge funds. 
STERIS PLC (STE) traded down 0.13% on Friday, hitting $82.08. 76,438 shares of the company traded hands. The stock has a market cap of $6.98 billion, a PE ratio of 64.12 and a beta of 1.33. The stock’s 50-day moving average is $81.32 and its 200 day moving average is $73.52. STERIS PLC has a 12 month low of $63.80 and a 12 month high of $83.54. 




STERIS PLC (NYSE:STE) last released its quarterly earnings data on Tuesday, May 9th. The medical equipment provider reported $1.11 EPS for the quarter, topping analysts’ consensus estimates of $1.07 by $0.04. The firm had revenue of $681.20 million for the quarter, compared to the consensus estimate of $673.47 million. STERIS PLC had a net margin of 4.20% and a return on equity of 11.12%. The firm’s revenue was down 1.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.90 earnings per share.  Equities research analysts expect that  STERIS PLC will post $4.04 earnings per share for the current fiscal year. 
The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 29th. Investors of record on Wednesday, June 7th were issued a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a yield of 1.36%. The ex-dividend date of this dividend  was Monday, June 5th. STERIS PLC’s dividend payout ratio  is currently 87.50%. 
COPYRIGHT VIOLATION WARNING: This news story was first  published by Daily Political and is the property of of Daily Political. If you are viewing this news story on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this news story can be viewed at https://www.dailypolitical.com/2017/07/21/legato-capital-management-llc-purchases-21948-shares-of-steris-plc-nyseste.html. 
STE has been the subject of several research analyst reports. Zacks Investment Research upgraded shares of STERIS PLC from a “hold” rating to a “buy” rating and set a $92.00 price target for the company in a research report on Tuesday, July 11th. Wellington Shields downgraded shares of STERIS PLC from a “gradually accumulate” rating to a “hold” rating in a research report on Monday, June 5th. Finally, KeyCorp upgraded shares of STERIS PLC from a “sector weight” rating to an “overweight” rating and set a $89.00 price target for the company in a research report on Wednesday, May 3rd. Two investment analysts have rated the stock with a hold rating and three have issued  a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $84.00.
In related news, insider Kathleen Bardwell sold 3,795 shares of the business’s stock in a transaction dated Friday, June 16th. The shares were sold at an average price of $82.00, for a total transaction of $311,190.00. Following the sale, the insider now owns 20,605 shares of the company’s stock, valued at $1,689,610. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Michael J. Tokich sold 13,600 shares of the business’s stock in a transaction dated Tuesday, May 9th. The stock was sold at an average price of $76.00, for a total transaction of $1,033,600.00. Following the sale, the chief financial officer now directly owns 58,106 shares in the company, valued at approximately $4,416,056. The disclosure for this sale can be found here. In the last three months, insiders have sold 60,880 shares of company stock worth $4,738,494. 2.55% of the stock is owned by insiders. 
STERIS PLC Company Profile
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS PLC (NYSE:STE).






Receive News & Ratings for STERIS PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS PLC and related companies with MarketBeat.com's FREE daily email newsletter.



 
















 Comment on this Post

Click here to cancel reply.



Name (required)

Mail (will not be published) (required)

Website






Wordpress Hashcash needs javascript to work, but your browser has javascript disabled. Your comment will be placed in moderation!




Latest News




Jeff Sessions Spoke of Resigning After Tensions Increase with Trump





President Trump’s Tweets Complicate Already Complicated Week





World Leaders Very Critical of Paris Agreement Decision by Trump





Aide to President Trump Resigns With More Expected





Scud-Class Missile Launched by North Korea














			© DailyPolitical, LLC 2009-2017. All rights reserved. 


Privacy Policy |
			About | Columnists 
			| Contact 



























































Insider Trading - Carestio Daniel A - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Carestio Daniel A





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2016-12-08Sale
2016-12-094:41 pm
Steris Plc
STE
Carestio Daniel ASr. V. P., Isomedix & Life Sci
2,225
$67.54
$150,273
20,025(Direct)
View


2016-08-12Sale
2016-08-154:23 pm
Steris Plc
STE
Carestio Daniel ASr. V. P., Isomedix & Life Sci
2,681
$71.04
$190,455
17,800(Direct)
View


2015-10-30Sale
2015-10-305:59 pm
Steris Corp
STE
Carestio Daniel ASr. V. P., Isomedix & Life Sci
6,270
$74
$463,967
22,470(Direct)
View


2015-10-20Sale
2015-10-224:31 pm
Steris Corp
STE
Carestio Daniel ASr. V. P., Isomedix & Life Sci
881
$68.25
$60,130
23,070(Direct)
View




Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-12-08Exercise
2016-12-094:41 pm
N/AN/A
Steris Plc
STE
Carestio Daniel ASr. V. P., Isomedix & Life Sci
2,225
$29.94
20,025(Direct)
View


2016-12-08Exercise
2016-12-094:41 pm
N/A2022-05-30
Steris Plc
STE
Carestio Daniel ASr. V. P., Isomedix & Life Sci
2,225
$29.94
20,025(Direct)
View


2016-05-31Tax Withholding
2016-06-024:27 pm
N/AN/A
Steris Plc
STE
Carestio Daniel ASr. V. P., Isomedix & Life Sci
1,819
$69.43
20,481(Direct)
View


2016-05-31Option Award
2016-06-024:27 pm
N/AN/A
Steris Plc
STE
Carestio Daniel ASr. V. P., Isomedix & Life Sci
2,500
$0
20,481(Direct)
View


2016-05-31Option Award
2016-06-024:27 pm
N/AN/A
Steris Plc
STE
Carestio Daniel ASr. V. P., Isomedix & Life Sci
3,000
$0
20,481(Direct)
View


2016-05-31Option Award
2016-06-024:27 pm
N/A2026-06-01
Steris Plc
STE
Carestio Daniel ASr. V. P., Isomedix & Life Sci
15,000
$69.72
20,481(Direct)
View


2015-11-02Option Award
2015-11-025:06 pm
N/AN/A
Steris Plc
STE
Carestio Daniel ASr. V. P., Isomedix & Life Sci
16,800
$0
16,800(Direct)
View


2015-11-02Option Award
2015-11-025:06 pm
N/A2022-05-30
Steris Plc
STE
Carestio Daniel ASr. V. P., Isomedix & Life Sci
2,225
$29.94
16,800(Direct)
View


2015-11-02Option Award
2015-11-025:06 pm
N/A2023-05-31
Steris Plc
STE
Carestio Daniel ASr. V. P., Isomedix & Life Sci
10,120
$45.34
16,800(Direct)
View


2015-11-02Option Award
2015-11-025:06 pm
N/A2024-05-30
Steris Plc
STE
Carestio Daniel ASr. V. P., Isomedix & Life Sci
7,000
$53.52
16,800(Direct)
View


2015-11-02Option Award
2015-11-025:06 pm
N/A2025-08-10
Steris Plc
STE
Carestio Daniel ASr. V. P., Isomedix & Life Sci
8,000
$67.98
16,800(Direct)
View


2015-11-02Disposition
2015-11-024:01 pm
N/AN/A
Steris Corp
STE
Carestio Daniel ASr. V. P., Isomedix & Life Sci
16,800
$0
0(Direct)
View


2015-11-02Disposition
2015-11-024:01 pm
N/A2022-05-30
Steris Corp
STE
Carestio Daniel ASr. V. P., Isomedix & Life Sci
2,225
$29.94
0(Direct)
View


2015-11-02Disposition
2015-11-024:01 pm
N/A2023-05-31
Steris Corp
STE
Carestio Daniel ASr. V. P., Isomedix & Life Sci
10,120
$45.34
0(Direct)
View


2015-11-02Disposition
2015-11-024:01 pm
N/A2024-05-30
Steris Corp
STE
Carestio Daniel ASr. V. P., Isomedix & Life Sci
7,000
$53.52
0(Direct)
View


2015-11-02Disposition
2015-11-024:01 pm
N/A2025-08-10
Steris Corp
STE
Carestio Daniel ASr. V. P., Isomedix & Life Sci
8,000
$67.98
0(Direct)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Thu, 27 Jul 2017 19:42:19 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  

















Daniel A. Carestio - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















Daniel A. Carestio
Sr. V. P. STE AST & Life Sci at Steris Plc


View Full Profile
Are you Daniel A. Carestio? Claim your profile


 


Sign up for Equilar Atlas and view Daniel A. Carestio's full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Daniel A. Carestio's  network and community.
												FOLLOW changes in Daniel A. Carestio's employment and money-in-motion.
												CONNECT with Daniel A. Carestio through your network of contacts.
												








Daniel A. Carestio's Executive Work History


Current


Sr. V. P. STE AST & Life Sci, 
Steris Plc


Past
To view Daniel A. Carestio's complete executive work history, sign up now
Age
44

 
 


Daniel A. Carestio's Biography




			Daniel A. Carestio serves as Senior Vice President, STERIS Applied Sterilization Technologies and Life Sciences. He assumed this role in August 2015. From 2011 to August 2015, he served as Vice President, Sales and Marketing for Isomedix Services and General Manager of Life Sciences.
		
Source: Steris Plc on 05/26/2017
		
	

 






Sign up for Equilar Atlas and view Daniel A. Carestio's full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Daniel A. Carestio. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Daniel A. Carestio's  network and community.
												FOLLOW changes in Daniel A. Carestio's employment and money-in-motion.
												CONNECT with Daniel A. Carestio through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Daniel A. Carestio


















Daniel A. Carestio's Connections (24)





Sign up now to view Daniel A. Carestio's 24 connections »









Jacqueline B. Kosecoff
Board Member, Steris Plc









Kevin M. McMullen
Former Chairman of the Board, Chief Executive Officer and President, OMNOVA Solutions Inc.









David B. Lewis
Board Member, H&R Block, Inc.









Adrian V. Coward
Senior Vice President, Healthcare Specialty Services, Steris Plc









Richard C. Breeden
Board Member, Steris Plc









Walter M. Rosebrough
Dir., President and Chief Executive Officer, Steris Plc









Michael B. Wood
Board Member, Steris Plc









John P. Wareham
Board Member, Steris Plc









John A. Zangerle
Vice President, General Counsel and Secretary, Steris Plc









Mohsen M. Sohi
Board Member, Steris Plc








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Carl G. Annessa
EVP and COO, Hornbeck Offshore Services, Inc.









Elon R. Musk
CEO and Chairman, Tesla









Michael C. Montgomery
Board Member, NMI Holdings, Inc.












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

� 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993





































$0.80 Earnings Per Share Expected for Steris Plc (NYSE:STE) This Quarter - Watch List News



















































Home
About
Staff
Privacy Policy
Contact
























Headlines
Business
US News
Health
World
Investing
Technology




















Steris Plc - Get News & Ratings Daily

		Enter your email address below to get the latest news and analysts' ratings for Steris Plc with our FREE daily email newsletter:



 






Follow Watchlist News

 











Latest News



Kosmos Energy Ltd. (NYSE:KOS) Given a $8.00 Price Target at Jefferies Group LLC					

Berenberg Bank Analysts Give Freeport-McMoran, Inc. (FCX) a $10.00 Price Target					

Insulet Corporation (NASDAQ:PODD) Earns “Hold” Rating from Oppenheimer Holdings, Inc.					

IBERIABANK Corporation (IBKC) Given a $95.00 Price Target at Stephens					

Maxim Group Analysts Give Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) a $8.00 Price Target					

Nordic American Tankers Limited (NYSE:NAT) PT Set at $5.00 by Maxim Group					

Northland Securities Reiterates “$7.00” Price Target for Bazaarvoice, Inc. (BV)					

Qualys, Inc. (NASDAQ:QLYS) Given a $48.00 Price Target at Northland Securities					

Synchrony Financial’s (SYF) Hold Rating Reiterated at Oppenheimer Holdings, Inc.					

Costco Wholesale Corporation (NASDAQ:COST) PT Set at $180.00 by Cowen and Company					

Marrone Bio Innovations, Inc. (MBII) Given a $1.00 Price Target by Piper Jaffray Companies Analysts					

Renewable Energy Group, Inc. (NASDAQ:REGI) PT Set at $13.00 by Piper Jaffray Companies					

Wells Fargo & Company Reiterates “$19.00” Price Target for Ironwood Pharmaceuticals, Inc. (IRWD)					

Kinder Morgan, Inc. (NYSE:KMI) Rating Reiterated by Raymond James Financial, Inc.					

Tallgrass Energy GP, LP (TEGP) PT Set at $28.00 by Scotiabank					

Delek Logistics Partners, L.P. (NYSE:DKL) Given a $33.00 Price Target at Scotiabank					

EQT Midstream Partners, LP (NYSE:EQM) Given a $94.00 Price Target at Scotiabank					

Evolution Petroleum Corp (EPM) Given a $10.00 Price Target at Scotiabank					

Rice Midstream Partners LP (RMP) PT Set at $22.00 by Scotiabank					

Scotiabank Reiterates $26.00 Price Target for Cheniere Energy Partners LP Holdings LLC (NYSE:CQH)					



Archives

July 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016
August 2016
July 2016
June 2016
May 2016
March 2016
November 2015
October 2015
September 2015
August 2015
July 2015
June 2015
May 2015
April 2015
March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014




 




						$0.80 Earnings Per Share Expected for Steris Plc (NYSE:STE) This Quarter					

						 July 19th, 2017  - 0 comments - Filed Under -
 by Hanz Christensen 


							Filed Under: Consensus Rating Articles - Investing 






Tweet










Wall Street analysts expect Steris Plc (NYSE:STE) to announce $0.80 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for Steris Plc’s earnings, with estimates ranging from $0.78 to $0.82. Steris Plc reported earnings per share of $0.79 in the same quarter last year, which would suggest a positive year-over-year growth rate of 1.3%. The company is scheduled to announce its next quarterly earnings report  on Tuesday, August 8th.
On average, analysts expect that Steris Plc will report full year earnings of $4.06 per share for the current year, with EPS estimates ranging from $4.05 to $4.08. For the next fiscal year, analysts anticipate that the firm will report earnings of $4.53 per share, with EPS estimates ranging from $4.51 to $4.57. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side analysts that cover Steris Plc.
Steris Plc (NYSE:STE) last announced its earnings results on Tuesday, May 9th. The medical equipment provider reported $1.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.07 by $0.04. The business had revenue of $681.20 million for the quarter, compared to analyst estimates of $673.47 million. Steris Plc had a net margin of 4.20% and a return on equity of 11.12%. The company’s revenue for the quarter was down 1.3% compared to the same quarter last year. During the same period last year, the firm posted $0.90 earnings per share. 




Several research analysts recently weighed in on the company. Zacks Investment Research raised Steris Plc from a “hold” rating to a “buy” rating and set a $92.00 target price for the company in a research note on Tuesday, July 11th. Wellington Shields downgraded Steris Plc from a “gradually accumulate” rating to a “hold” rating in a report on Monday, June 5th. Finally, KeyCorp raised Steris Plc from a “sector weight” rating to an “overweight” rating and set a $89.00 target price for the company in a report on Wednesday, May 3rd. Two equities research analysts have rated the stock with a hold rating and three have issued  a buy rating to the company. Steris Plc presently has a consensus rating of “Buy” and a consensus price target of $84.00.
In other Steris Plc news, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the firm’s stock in a transaction that occurred on Friday, June 2nd. The stock was sold at an average price of $80.05, for a total value of $800,500.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Michael J. Tokich sold 13,600 shares of the firm’s stock in a transaction that occurred on Tuesday, May 9th. The shares were sold at an average price of $76.00, for a total value of $1,033,600.00. Following the completion of the sale, the chief financial officer now directly owns 58,106 shares in the company, valued at approximately $4,416,056. The disclosure for this sale can be found here. Insiders have sold a total of 60,880 shares of company stock valued at $4,738,494 over the last ninety days. Company insiders own  2.55% of the company’s stock. 
Hedge funds have recently added to or reduced their stakes in the stock. Louisiana State Employees Retirement System increased its stake in shares of  Steris Plc by 1.4% in the first quarter. Louisiana State Employees Retirement System now owns 21,400 shares of the medical equipment provider’s stock worth $1,486,000 after buying an additional 300 shares in the last quarter.  Norges Bank bought a new position in  Steris Plc during the fourth quarter valued at approximately $45,178,000.  Russell Investments Group Ltd. increased its position in  Steris Plc by 57.5% in the first quarter. Russell Investments Group Ltd. now owns 132,035 shares of the medical equipment provider’s stock valued at $9,171,000 after buying an additional 48,188 shares during the period.  Washington Capital Management Inc. increased its position in  Steris Plc by 35.6% in the first quarter. Washington Capital Management Inc. now owns 8,000 shares of the medical equipment provider’s stock valued at $556,000 after buying an additional 2,100 shares during the period.  Finally, Bragg Financial Advisors Inc bought a new position in  Steris Plc during the first quarter valued at approximately $1,159,000. 90.43% of the stock is currently owned by hedge funds and other institutional investors. 
TRADEMARK VIOLATION WARNING: “$0.80 Earnings Per Share Expected for Steris Plc (NYSE:STE) This Quarter” was first  published by Watch List News and is owned by of Watch List News. If you are reading this article on another domain, it was copied illegally and reposted in violation of United States and international trademark and copyright legislation. The legal version of this article can be read at https://www.watchlistnews.com/0-80-earnings-per-share-expected-for-steris-plc-nyseste-this-quarter/1452833.html. 
Steris Plc (NYSE:STE) opened at 81.91 on Wednesday. The stock has a market capitalization of $6.96 billion, a price-to-earnings ratio of 63.99 and a beta of 1.33. Steris Plc has a 52-week low of $63.80 and a 52-week high of $83.54. The company has a 50-day moving average of $81.05 and a 200-day moving average of $73.40. 
The company also recently declared a quarterly dividend, which was paid on Thursday, June 29th. Stockholders of record on Wednesday, June 7th were paid a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.37%. The ex-dividend date  was Monday, June 5th. Steris Plc’s dividend payout ratio (DPR) is presently 87.50%. 
About Steris Plc
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Get a free copy of the Zacks research report on Steris Plc (STE)
For more information about research offerings from Zacks Investment Research, visit Zacks.com


Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with Analyst Ratings Network's FREE daily email newsletter.



 










Hanz Christensen 























 Comment on this Post

Click here to cancel reply.



Name (required)

Mail (will not be published) (required)

Website






Wordpress Hashcash needs javascript to work, but your browser has javascript disabled. Your comment will be placed in moderation!




Latest News




Sirius XM Making Big Investment In Pandora





Tax Reform Not Going Quite As Planned





Western Digital Files Lawsuit To Halt Toshiba Chip Business Sale





Sinclair Broadcast Group Announces Deal For Tribune Media





Starbucks Has A Hit With Its Unicorn Frappuccino











			© Watch List News, LLC 2008-2017. All rights reserved. 


Privacy Policy |
			About | Staff 
			| Contact 










































